These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38943091)

  • 21. Availability of stage at diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry indicators for cancer care in Europe: Results of EUROCHIP-3 survey.
    Siesling S; Kwast A; Gavin A; Baili P; Otter R;
    Int J Cancer; 2013 Jun; 132(12):2910-7. PubMed ID: 23180472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study.
    Li M; Roder D; D'Onise K; Walters D; Farshid G; Buckley E; Karapetis C; Joshi R; Price T; Townsend A; Miller CL; Currow D; Powell K; Buranyi-Trevarton D; Olver I
    BMJ Open; 2020 Jun; 10(6):e037069. PubMed ID: 32595164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Registries are not only a tool for data collection, they are for action": Cancer registration and gaps in data for health equity in six population-based registries in India.
    Bhatia A; Victora CG; Beckfield J; Budukh A; Krieger N
    Int J Cancer; 2021 May; 148(9):2171-2183. PubMed ID: 33186475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries.
    Soerjomataram I; Cabasag C; Bardot A; Fidler-Benaoudia MM; Miranda-Filho A; Ferlay J; Parkin DM; Ranganathan R; Piñeros M; Znaor A; Mery L; Joko-Fru YW; Dikshit R; Sankaranarayanan R; Swaminathan R; Bray F;
    Lancet Oncol; 2023 Jan; 24(1):22-32. PubMed ID: 36603919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population Based Cancer Registry of India – the Challenges and Opportunities.
    Behera P; Patro BK
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2885-2889. PubMed ID: 30362317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.
    Chen VW; Ruiz BA; Hsieh MC; Wu XC; Ries LA; Lewis DR
    Cancer; 2014 Dec; 120 Suppl 23(0 0):3781-92. PubMed ID: 25412390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level.
    Hsieh MC; Yu Q; Wu XC; Wohler B; Fan Y; Qiao B; Jemal A; Ajani UA
    J Registry Manag; 2012; 39(3):101-6. PubMed ID: 23443453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incompleteness trends of epidemiological variables in a Brazilian high complexity cancer registry: An ecological time series study.
    Grippa WR; Dell'Antonio LS; Salaroli LB; Lopes-Júnior LC
    Medicine (Baltimore); 2023 Aug; 102(31):e34369. PubMed ID: 37543818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing cancer registry data for comparative effectiveness research (CER) project: overview and methodology.
    Chen VW; Eheman CR; Johnson CJ; Hernandez MN; Rousseau D; Styles TS; West DW; Hsieh M; Hakenewerth AM; Celaya MO; Rycroft RK; Wike JM; Pearson M; Brockhouse J; Mulvihill LG; Zhang KB
    J Registry Manag; 2014; 41(3):103-12. PubMed ID: 25419602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Completeness of T, N, M and stage grouping for all cancers in the Mallorca Cancer Registry.
    Ramos M; Franch P; Zaforteza M; Artero J; Durán M
    BMC Cancer; 2015 Nov; 15():847. PubMed ID: 26537005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
    Gershenwald JE; Scolyer RA; Hess KR; Sondak VK; Long GV; Ross MI; Lazar AJ; Faries MB; Kirkwood JM; McArthur GA; Haydu LE; Eggermont AMM; Flaherty KT; Balch CM; Thompson JF;
    CA Cancer J Clin; 2017 Nov; 67(6):472-492. PubMed ID: 29028110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cancer registration in Korea: the present and furtherance].
    Ahn YO
    J Prev Med Public Health; 2007 Jul; 40(4):265-72. PubMed ID: 17693728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines.
    Gupta S; Aitken JF; Bartels U; Brierley J; Dolendo M; Friedrich P; Fuentes-Alabi S; Garrido CP; Gatta G; Gospodarowicz M; Gross T; Howard SC; Molyneux E; Moreno F; Pole JD; Pritchard-Jones K; Ramirez O; Ries LAG; Rodriguez-Galindo C; Shin HY; Steliarova-Foucher E; Sung L; Supriyadi E; Swaminathan R; Torode J; Vora T; Kutluk T; Frazier AL
    Lancet Oncol; 2016 Apr; 17(4):e163-e172. PubMed ID: 27300676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
    Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
    Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system.
    Chen VW; Hsieh MC; Charlton ME; Ruiz BA; Karlitz J; Altekruse SF; Ries LA; Jessup JM
    Cancer; 2014 Dec; 120 Suppl 23(0 0):3793-806. PubMed ID: 25412391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
    Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
    Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of cancer diagnoses and staging in South Western Victoria: a rural perspective.
    Banks P; Matheson LM; Morrissy K; Olesen I; Pitson G; Chapman A; Ashley DM; Henry MJ
    Aust J Rural Health; 2014 Oct; 22(5):257-63. PubMed ID: 25303418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing information on stage at diagnosis of cancer in Africa.
    Parkin DM; Liu B; Adoubi I; Makouanzi AS; Masalu N; Mrema C; Ndlovu N; Omonisi A; Traore B; Joko-Fru Y
    Acta Oncol; 2023 Apr; 62(4):335-341. PubMed ID: 37102435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.